11月 2025
- 首頁
- PRA Health Sciences
11月 2025PRA Health Sciences的市場佔有率分析
icon is the world's leading clinical research organisation,
providing outsourced clincal development and commercialisation
services to the pharmaceutical, biotechnology and medical
device
industries.
PRA Health Sciences(包含公司地區)
查看更多網站流量與參與度資訊- prahs.com
PRA Health Sciences截至 11月 2025 的總收入為 > 1B
PRA Health Sciences 熱門網域產生的總收入
PRA Health Sciences 熱門網域 3 年內的總收入
PRA Health Sciences 熱門網域的總收入
PRA Health Sciences的熱門網域總造訪量
了解PRA Health Sciences市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
PRA Health Sciences的熱門網域平均造訪時長
分析PRA Health Sciences參與度指標。
過去 3 個月平均造訪時長
無可顯示數據
無可顯示數據
PRA Health Sciences的熱門網域平均頁面瀏覽量
了解PRA Health Sciences如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自PRA Health Sciences
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Maharishi Ayurveda Products International, Inc. partners with Prahs.It’s nearly a year since Mapi Group joined forces with PRA Health Sciences and as a company, Mapi Group has never been more diverse.
5月 24, 2022閱讀更多
新聞Prahs launches vaccines and therapeutics for COVID-19.PRA Health Sciences has expanded its pharmacovigilance solutions to include a broader range of post-marketing services geared toward authorized vaccines and therapeutics for COVID-19.
5月 4, 2021閱讀更多
新聞ICON plc acquired Prahs for $12B on Mar 3rd '21.Management's response to a potential period of consolidation as opposed to sector-leading growth has been to turn to M&A, however, as on Feb. 24 ICON announced that it would acquire competitor PRA Health Sciences ( PRAH ) in a $12bn deal, with PRA shareholders receiving $80 in cash and 0.4125 shares of ICON stock per share.
4月 3, 2021閱讀更多
查看所有PRA Health Sciences信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。